The Importance of Clinical Trials in Myeloma - HealthTree for Multiple Myeloma
[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

The Importance of Clinical Trials in Myeloma

The Importance of Clinical Trials in Myeloma image

The Importance of Clinical Trials in Myeloma

Webinar
event Sep 20, 2023 / 06:30PM - 08:00PM MDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Dr. John Burke joins the Mountain West Myeloma Community to talk about the importance of clinical trials. What are common clinical trial myths that our community still believes? What hindrances keep myeloma patients from participating in clinical trials? What clinical trials are open and available in our region?

Learn with us and come with your questions for a great discussion.

Schedule & Agenda

The panelist Audrey Burton-Bethke
6:30 PM
Introductions
Audrey Burton-Bethke

Audrey introduces the agenda of the event and our featured speaker Dr. John Burke.

The panelist Dr. John Burke
6:35 PM
Presentation
Dr. John Burke

Dr. John Burke talks about the importance of clinical trials.

Event panelist Audience
7:05 PM
Questions and Answers
Audience

Type your questions in the chat and we will answer them! 

Event panelist Audience
7:35 PM
Announcements and Post Meeting Mingle
Audience

Speakers & Moderators

The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist Dr. John Burke
Dr. John Burke

Dr. John Burke is a board-certified hematologist and medical oncologist who joined Rocky Mountain Cancer Centers in 2003. He specializes in blood cancers, with an emphasis on lymphoid disorders, including lymphomas, chronic lymphocytic leukemia (CLL), and multiple myeloma. Dr. Burke is considered a national and international expert in blood cancers, lecturing primarily on lymphoid malignancies. He is very active in clinical research, helping to develop new therapies for lymphoid malignancies, and has published numerous articles in peer-reviewed medical journals, including the New England Journal of Medicine, Blood, and the Journal of Clinical Oncology. Dr. Burke contributes to maximizing the quality of medical publications, serving as Editor-in-Chief for Targeted Therapies in Oncology and as an Associate Editor for JCO Oncology Practice. He is active in hematology and oncology professional societies, having recently served a term on the Ethics Committee of the American Society of Clinical Oncology (ASCO) and currently serving a term on the Committee on Practice of the American Society of Hematology (ASH).

Read Bio
HealthTree Connect Icon

Join the Conversation

This event is part of the Rocky Mountain Regional Cure Team group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Adaptive logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.